Pancreatic Cancer Research

ResearcherKyushu UniversityNo recent work listed

Lin Cui

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5797-9323; OpenAlex author ID A5101535427. Sources: OpenAlex.

Their work

Papers
13
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2011: 3 papers · 2012: 1 paper · 2013: 4 papers · 2014: 1 paper · 2015: 1 paper · 2016: 2 papers · 2017: 1 paper

Papers 13

  1. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envel… Co-author DOI 10.1053/j.gastro.2017.03.050↗
  2. Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and … Co-author DOI 10.1002/ijc.30075↗
  3. CD146 attenuation in cancer-associated fibroblasts promotes pancreatic cancer progression. Co-author DOI 10.1002/mc.22409↗
  4. TM4SF1 as a prognostic marker of pancreatic ductal adenocarcinoma is involved in migration and invasion of cancer cells. Co-author DOI 10.3892/ijo.2015.3022↗
  5. Peritoneal myofibroblasts at metastatic foci promote dissemination of pancreatic cancer. Co-author DOI 10.3892/ijo.2014.2391↗
  6. MAL2 expression predicts distant metastasis and short survival in pancreatic cancer. Co-author DOI 10.1016/j.surg.2013.03.010↗
  7. Migratory activity of CD105+ pancreatic cancer cells is strongly enhanced by pancreatic stellate cells. Co-author DOI 10.1097/mpa.0b013e318293e7bd↗
  8. Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells. Co-author DOI 10.1158/0008-5472.can-12-3180↗
  9. S100A4 mRNA expression level is a predictor of radioresistance of pancreatic cancer cells. Co-author DOI 10.3892/or.2013.2636↗
  10. MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene. Co-author DOI 10.1245/s10434-012-2252-3↗
  11. MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis. Co-author DOI 10.1016/j.surg.2011.06.017↗
  12. Insig2 is overexpressed in pancreatic cancer and its expression is induced by hypoxia. Co-author DOI 10.1111/j.1349-7006.2011.01936.x↗
  13. Adenoviral therapy is more effective in gemcitabine-resistant pancreatic cancer than in gemcitabine-sensitive cells. Co-author PMID 21508376↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masao Tanaka · 12 shared papers, 2011–2016 · strength 0.43
  2. Kenoki Ohuchida · 11 shared papers, 2011–2016 · strength 0.37
  3. Takao Ohtsuka · 8 shared papers, 2011–2016 · strength 0.29
  4. Kenji Fujiwara · 6 shared papers, 2013–2015 · strength 0.22
  5. Yoshinao Oda · 5 shared papers, 2011–2016 · strength 0.21
  6. Naoki Ikenaga · 5 shared papers, 2011–2014 · strength 0.16
  7. Ming Zhao · 4 shared papers, 2011–2016 · strength 0.15
  8. Daiki Eguchi · 4 shared papers, 2013–2014 · strength 0.14
  9. Shingo Kozono · 4 shared papers, 2013–2014 · strength 0.14
  10. Satoshi Obika · 2 shared papers, 2016–2017 · strength 0.13
  11. Yusuke Mizuuchi · 2 shared papers, 2016 · strength 0.11
  12. Koji Shindo · 3 shared papers, 2013–2015 · strength 0.11
  13. Biao Zheng · 2 shared papers, 2015–2016 · strength 0.09
  14. Makoto Hashizume · 2 shared papers, 2012–2016 · strength 0.08
  15. Masafumi Nakamura · 2 shared papers, 2012–2016 · strength 0.08
  16. Hayato Fujita · 3 shared papers, 2011 · strength 0.07
  17. Kazuaki Shimada · 1 shared paper, 2017 · strength 0.07
  18. Nobuyoshi Hiraoka · 1 shared paper, 2017 · strength 0.07
  19. Shin Akagawa · 2 shared papers, 2013–2014 · strength 0.07
  20. Mitsuo Katano · 1 shared paper, 2016 · strength 0.06
  21. Kentaro Shinkai · 1 shared paper, 2016 · strength 0.06
  22. Hideya Onishi · 1 shared paper, 2016 · strength 0.06
  23. Kohei Horioka · 1 shared paper, 2016 · strength 0.05
  24. Yoshiro Chijiiwa · 1 shared paper, 2016 · strength 0.05
  25. Tadashi Kayashima · 2 shared papers, 2011 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.